Posted in | News | Nanoanalysis

Nanotechnology Company Named as One of Four Finalists in The 2008 Royal Academy of Engineering MacRobert Awards Competition

Advance Nanotech, Inc., announced today that its Owlstone Nanotech Inc. subsidiary has been selected as one of four finalists for the 2008 Royal Academy of Engineering MacRobert Award, the UK's premier award for innovation in engineering.  HRH the Duke of Edinburgh will present a 50,000 pounds Sterling prize and the gold award medal to the winner of this year's competition at the Academy Awards Dinner in London on June 9th, 2008.  The MacRobert award recognizes the successful development of innovative ideas in engineering.  The academy seeks to demonstrate the importance of engineering and the role of engineers and scientists in contribution to national prosperity and internal prestige.

"Our technology enables unprecedented miniaturization of sensors with superior analytical capability, the ability to be programmed and reprogrammed to detect a wide range of substances, and high selectivity and sensitivity," commented Andrew Koehl, founder of Owlstone and original inventor of its core technology. "Our commercial opportunity is enormous given the need for new and innovative deployment scenarios in chemical detection for homeland security, industrial process control, environmental and healthcare markets.  We are deeply honored to be chosen as a finalist candidate for the prestigious MacRobert Award and are proud to be recognized among the three highly regarded companies that have also achieved 2008 finalist status, The Automation Partnership, Johnson Matthey, and Touch Bionics."

Owlstone has successfully developed a silicon chip that can detect chemicals in the ambient air.  What once required a large enclosure and connected apparatus due to the sheer size of conventional sensors has been reduced down to a dime sized silicon chip that can detect a wide variety of chemicals in real time from virtually any location.  The system can then be connected to a wireless communication system to send back real-time results to a command station.  Owlstone's proprietary FAIMS technology offers the flexibility to provide rapid alerts and detailed sample analysis with reduced flow and improved ion drive over current conventional technology. The performances of existing systems, which largely use conventional Ion Mobility Spectrometry, worsen dramatically as they are reduced in size. By contrast, the Owlstone FAIMS solution has improved sensitivity, improved selectivity at reduced power as it is miniaturized. The small size of the Owlstone sensor enables a highly integrated system with the necessary electronic and mechanical components squeezed into a compact footprint. Micro and nano-fabrication techniques enable the sensor to be manufactured in a massively parallel fashion, achieving small form factor, economy of scale and reduced unit cost. Unlike alternate miniature detectors, Owlstone's technology does not rely on exotic materials, custom engineered for each application, which often degrade over time. The Owlstone technology is easily customized to each application through software updates and can be dynamically reprogrammed for new chemicals even after deployment. Use of chemically inert materials ensures a long operational and storage life.

The Owlstone detector was conceived by Andrew Koehl who began the development of Owlstone's fundamental technology in 2001 at Caltech (California Institute of Technology) with further development at Cambridge University, England. Mr. Koehl is the inventor of the microchip spectrometer technology, the core of the Owlstone technology.  That technology was furthered as he was later joined by Paul Boyle, a researcher in the Microsystems and Nanotech group at Cambridge University responsible for the design and development of the silicon-opto hybrid devices for next generation telecom systems, and David Ruiz-Alonso, a Cambridge University PhD in superconductor modeling.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.